New York, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Neuromodulation Industry" - https://www.reportlinker.com/p05957502/?utm_source=GNW
8 Billion by 2027, growing at a CAGR of 12.4% over the analysis period 2020-2027. Deep brain stimulation, one of the segments analyzed in the report, is projected to record a 11.2% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sacral nerve stimulation segment is readjusted to a revised 12.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 12% CAGR
The Neuromodulation market in the U.S. is estimated at US$2.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2027 trailing a CAGR of 12.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 10.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.
Vagus nerve stimulation Segment to Record 9.5% CAGR
In the global Vagus nerve stimulation segment, USA, Canada, Japan, China and Europe will drive the 9.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$2.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.1 Billion by the year 2027.We bring years of research experience to this 8th edition of our report. The 161-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- Abbott Laboratories
- Aleva Neurotherapeutics SA
- Bioness Inc.
- Boston Scientific Corporation
- EnteroMedics, Inc.
- LivaNova PLC
- Medtronic PLC
- NeuroPace, Inc.
- Nevro Corp.
Read the full report: https://www.reportlinker.com/p05957502/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Neuromodulation Competitor Market Share Scenario Worldwide
(in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Neuromodulation Global Market Estimates and Forecasts
in US$ Million by Region/Country: 2020-2027
Table 2: Neuromodulation Market Share Shift across Key
Geographies Worldwide: 2020 VS 2027
Table 3: Deep brain stimulation (Technology) World Market by
Region/Country in US$ Million: 2020 to 2027
Table 4: Deep brain stimulation (Technology) Market Share
Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
Table 5: Sacral nerve stimulation (Technology) Potential Growth
Markets Worldwide in US$ Million: 2020 to 2027
Table 6: Sacral nerve stimulation (Technology) Market Sales
Breakdown by Region/Country in Percentage: 2020 VS 2027
Table 7: Vagus nerve stimulation (Technology) Geographic Market
Spread Worldwide in US$ Million: 2020 to 2027
Table 8: Vagus nerve stimulation (Technology) Market Share
Distribution in Percentage by Region/Country: 2020 VS 2027
Table 9: Spinal cord stimulation (Technology) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2020
to 2027
Table 10: Spinal cord stimulation (Technology) Market Share
Breakdown by Region/Country: 2020 VS 2027
Table 11: Transcutaneous electrical nerve stimulation
(Technology) World Market by Region/Country in US$ Million:
2020 to 2027
Table 12: Transcutaneous electrical nerve stimulation
(Technology) Market Share Distribution in Percentage by
Region/Country: 2020 VS 2027
Table 13: Repetitive transcranial magnetic stimulation
(Technology) World Market Estimates and Forecasts in US$
Million by Region/Country: 2020 to 2027
Table 14: Repetitive transcranial magnetic stimulation
(Technology) Market Percentage Share Distribution by
Region/Country: 2020 VS 2027
Table 15: Other Neurostimulators (Technology) Market
Opportunity Analysis Worldwide in US$ Million by
Region/Country: 2020 to 2027
Table 16: Other Neurostimulators (Technology) Market Share
Distribution in Percentage by Region/Country: 2020 VS 2027
Table 17: Failed Back Syndrome (Application) Worldwide Sales in
US$ Million by Region/Country: 2020-2027
Table 18: Failed Back Syndrome (Application) Market Share Shift
across Key Geographies: 2020 VS 2027
Table 19: Chronic Pain (Application) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2020-2027
Table 20: Chronic Pain (Application) Market Share Breakdown by
Region/Country: 2020 VS 2027
Table 21: Depression (Application) Demand Potential Worldwide
in US$ Million by Region/Country: 2020-2027
Table 22: Depression (Application) Share Breakdown Review by
Region/Country: 2020 VS 2027
Table 23: Gastroparesis (Application) Worldwide Latent Demand
Forecasts in US$ Million by Region/Country: 2020-2027
Table 24: Gastroparesis (Application) Distribution of Global
Sales by Region/Country: 2020 VS 2027
Table 25: Migraine (Application) Sales Estimates and Forecasts
in US$ Million by Region/Country for the Years 2020 through
2027
Table 26: Migraine (Application) Global Market Share
Distribution by Region/Country for 2020 and 2027
Table 27: Other Applications (Application) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027
Table 28: Other Applications (Application) Percentage Share
Breakdown of Global Sales by Region/Country: 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Neuromodulation Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 29: Neuromodulation Market in US$ Million in the United
States by Technology: 2020-2027
Table 30: United States Neuromodulation Market Share Breakdown
by Technology: 2020 VS 2027
Table 31: United States Neuromodulation Latent Demand Forecasts
in US$ Million by Application: 2020 to 2027
Table 32: Neuromodulation Market Share Breakdown in the United
States by Application: 2020 VS 2027
CANADA
Table 33: Neuromodulation Market Analysis in Canada in US$
Million by Technology: 2020-2027
Table 34: Canadian Neuromodulation Market Share Breakdown by
Technology: 2020 VS 2027
Table 35: Canadian Neuromodulation Market Quantitative Demand
Analysis in US$ Million by Application: 2020 to 2027
Table 36: Canadian Neuromodulation Market Share Analysis by
Application: 2020 VS 2027
JAPAN
Table 37: Japanese Medium & Long-Term Outlook for
Neuromodulation Market in US$ Million by Technology: 2020-2027
Table 38: Japanese Neuromodulation Market Percentage Share
Distribution by Technology: 2020 VS 2027
Table 39: Japanese Demand Estimates and Forecasts for
Neuromodulation in US$ Million by Application: 2020 to 2027
Table 40: Neuromodulation Market Share Shift in Japan by
Application: 2020 VS 2027
CHINA
Table 41: Neuromodulation Market Estimates and Forecasts in
China in US$ Million by Technology: 2020-2027
Table 42: Neuromodulation Market in China: Percentage Share
Analysis by Technology for 2020 and 2027
Table 43: Chinese Demand for Neuromodulation in US$ Million by
Application: 2020 to 2027
Table 44: Chinese Neuromodulation Market Share Breakdown by
Application: 2020 VS 2027
EUROPE
Market Facts & Figures
European Neuromodulation Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 45: European Neuromodulation Market Demand Scenario in
US$ Million by Region/Country: 2018-2025
Table 46: European Neuromodulation Market Share Shift by
Region/Country: 2020 VS 2027
Table 47: European Neuromodulation Market Assessment in US$
Million by Technology: 2020-2027
Table 48: Neuromodulation Market in Europe: Percentage
Breakdown of Sales by Technology for 2020 and 2027
Table 49: European Neuromodulation Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 50: European Neuromodulation Market Share Analysis by
Application: 2020 VS 2027
FRANCE
Table 51: French Neuromodulation Market Estimates and
Projections in US$ Million by Technology: 2020-2027
Table 52: French Neuromodulation Market Share Breakdown by
Technology: 2020 VS 2027
Table 53: Neuromodulation Quantitative Demand Analysis in
France in US$ Million by Application: 2020-2027
Table 54: French Neuromodulation Market Share Analysis:
A 7-Year Perspective by Application for 2020 and 2027
GERMANY
Table 55: German Neuromodulation Latent Demand Forecasts in US$
Million by Technology: 2020-2027
Table 56: German Neuromodulation Market Share Breakdown by
Technology: 2020 VS 2027
Table 57: Neuromodulation Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2020-2027
Table 58: Neuromodulation Market Share Distribution in Germany
by Application: 2020 VS 2027
ITALY
Table 59: Neuromodulation Market Estimates and Forecasts in
Italy in US$ Million by Technology: 2020-2027
Table 60: Neuromodulation Market in Italy: Percentage Share
Analysis by Technology for 2020 and 2027
Table 61: Italian Demand for Neuromodulation in US$ Million by
Application: 2020 to 2027
Table 62: Italian Neuromodulation Market Share Breakdown by
Application: 2020 VS 2027
UNITED KINGDOM
Table 63: United Kingdom Medium & Long-Term Outlook for
Neuromodulation Market in US$ Million by Technology: 2020-2027
Table 64: United Kingdom Neuromodulation Market Percentage
Share Distribution by Technology: 2020 VS 2027
Table 65: United Kingdom Demand Estimates and Forecasts for
Neuromodulation in US$ Million by Application: 2020 to 2027
Table 66: Neuromodulation Market Share Shift in the United
Kingdom by Application: 2020 VS 2027
REST OF EUROPE
Table 67: Rest of Europe Neuromodulation Market Assessment in
US$ Million by Technology: 2020-2027
Table 68: Neuromodulation Market in Rest of Europe: Percentage
Breakdown of Sales by Technology for 2020 and 2027
Table 69: Rest of Europe Neuromodulation Addressable Market
Opportunity in US$ Million by Application: 2020-2027
Table 70: Rest of Europe Neuromodulation Market Share Analysis
by Application: 2020 VS 2027
ASIA-PACIFIC
Table 71: Asia-Pacific Neuromodulation Market Estimates and
Projections in US$ Million by Technology: 2020-2027
Table 72: Asia-Pacific Neuromodulation Historic Market Analysis
in US$ Million by Technology: 2020 VS 2027
Table 73: Neuromodulation Quantitative Demand Analysis in
Asia-Pacific in US$ Million by Application: 2020-2027
Table 74: Asia-Pacific Neuromodulation Market Share Analysis:
A 7-Year Perspective by Application for 2020 and 2027
REST OF WORLD
Table 75: Neuromodulation Market Analysis in Rest of World in
US$ Million by Technology: 2020-2027
Table 76: Rest of World Neuromodulation Market Share Breakdown
by Technology: 2020 VS 2027
Table 77: Rest of World Neuromodulation Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027
Table 78: Rest of World Neuromodulation Market Share Analysis
by Application: 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 47
Read the full report: https://www.reportlinker.com/p05957502/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________